Wearable Injectors Market Global Industry, Share, Opportunity and Forecast 2023-2028
The
latest report by IMARC Group, titled “Wearable Injectors Market: Global Industry Trends,
Share, Size, Growth, Opportunity and Forecast 2023-2028“. The
global wearable injectors market size reached US$ 6.6 Billion in
2022. Looking forward, IMARC Group expects the market to reach US$ 15.6 Billion
by 2028, exhibiting a growth rate (CAGR) of 14.8% during 2023-2028.
Wearable
injectors, also known as wearable drug delivery devices, represent a
significant advancement in the field of medical technology. These innovative
devices are designed to provide a convenient and patient-friendly method for
administering medications, particularly for chronic conditions that require
frequent dosing. A wearable injector is typically worn on the patient's body,
often in the form of a patch or an easily attachable device. It incorporates a
mechanism for controlled and programmable drug delivery, ensuring precise
dosing at scheduled intervals. This technology is especially beneficial for
individuals who require long-term treatment, such as those with diabetes,
multiple sclerosis, or autoimmune disorders.
Request For Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/wearable-injectors-market/requestsample
Wearable Injectors Market Trends and Drivers:
The
prevalence of chronic diseases, such as diabetes, cardiovascular conditions,
and autoimmune disorders, is on the rise worldwide. Wearable
injectors offer an effective means to manage these conditions by providing
convenient and consistent drug administration, thus driving market growth.
Additionally, there is a growing emphasis on patient-centric healthcare, with a
focus on improving patient experience and outcomes. Wearable
injectors empower patients to take control of their treatment, promoting
adherence and reducing the need for frequent hospital visits. Other than this,
the increasing use of biologics and other complex drugs necessitates precise
dosing and controlled delivery. Wearable injectors are well-suited
for administering these medications, further boosting their demand in the
healthcare sector. In line with this, the use of wearable
injectors in clinical trials is growing, as they enable precise dosing and
real-time data collection. Pharmaceutical companies are increasingly adopting
these devices to enhance their drug development processes. Besides this,
ongoing advancements in wearable injector technology have led to more user-friendly
and efficient devices. Integration with smartphone apps for monitoring and dose
management adds to their appeal.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Type:
- On-body
- Off-body
Breakup by Technology:
- Spring-based
- Motor-driven
- Rotary Pump
- Expanding Battery
- Others
Breakup by Application:
- Oncology
- Infectious
Diseases
- Cardiovascular
Diseases
- Autoimmune
Diseases
- Others
Breakup by End Use:
- Hospitals and
Clinics
- Home Care
- Others
Market Breakup by Region:
- North America
(United States, Canada)
- Asia Pacific
(China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany,
France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America
(Brazil, Mexico, Others)
- Middle East and
Africa
Competitive Landscape with Key Player:
- CeQur SA
- Debiotech SA
- Dexcom Inc.
- Enable Injections
Inc.
- Gerresheimer AG
- Insulet
Corporation
- Tandem Diabetes
Care Inc.
- West
Pharmaceutical Services Inc
- Ypsomed AG.
Explore full report with table of contents: https://www.imarcgroup.com/wearable-injectors-market
If you need specific information that is not currently within the
scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC
Group is a leading market research company that offers management strategy and
market research worldwide. We partner with clients in all sectors and regions
to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s
information products include major market, scientific, economic and
technological developments for business leaders in pharmaceutical, industrial, and
high technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel
and tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
Contact Us
IMARC
Group
Email:
sales@imarcgroup.com
USA:
+1-631-791-1145 | Asia: +91-120-433-0800
Address:
134 N 4th St. Brooklyn, NY 11249, USA
Follow
us on Twitter: @imarcglobal
Comments
Post a Comment